LD-38 is a drug-linker conjugate for ADC . LD-38 consists of a topoisomerase 1 inhibitor (Exatecan) ( HY-13631 ) and a highly hydrophilic stable and cleavable linker . LD-38 can be used for synthesis of ADCs, such as KA-3123-LD38.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Drug-Linker Conjugates for ADC | Products > Signaling Pathways > Topoisomerase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.